Lanean...
Isocitrate dehydrogenase 1 mutation subtypes at site 132 and their translational potential in glioma
In recent years, de novo missense structural mutations in the IDH1 gene of arginine at site 132 (R132) have become a standard for diagnostication and prognostication in glioma management. As our clinical understanding of this mutation grows, so too does the number of mutation subtypes reported in th...
Gorde:
| Argitaratua izan da: | CNS Oncol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Future Medicine Ltd
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6001689/ https://ncbi.nlm.nih.gov/pubmed/29303363 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns-2017-0019 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|